ADVANCED MALIGNANT TUMORS
Clinical trials for ADVANCED MALIGNANT TUMORS explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMORS trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope drug enters first human tests for tough cancers
Disease control Recruiting nowThis is the first study in people to test a new drug called SSGJ-709 for advanced cancers. The main goals are to find a safe dose and see how the body processes the drug. It will involve about 15 patients with various advanced cancers who have no other standard treatment options …
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test of experimental cancer drug begins
Disease control Recruiting nowThis is the first human study of an experimental cancer drug called TQB6411. Researchers are testing its safety, how it moves through the body, and looking for early signs that it might help control advanced cancers. The study will enroll 216 adults whose cancers have progressed …
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New cancer drug enters first human testing for advanced tumors
Disease control Recruiting nowThis early-stage study is testing a new cancer drug called SPGL008 in patients with advanced tumors that have spread or cannot be removed by surgery. The main goal is to find the safest dose and see how well patients tolerate the drug when given either through an IV or injection …
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1 • Sponsor: Shenyang Sunshine Pharmaceutical Co., LTD. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New cancer drug begins human testing in major trial
Disease control Recruiting nowThis study is testing a new drug called JMT108 in adults with advanced cancers that have not responded to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it can shrink tumors. It is an early-stage tri…
Matched conditions: ADVANCED MALIGNANT TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai JMT-Bio Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC